ARREST - A Phase I Study of SABR for Poly-metastatic Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Metastatic Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentIntervention Model Description: Dose Escalation StudyMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04530513
- Collaborators
- Ontario Institute for Cancer Research
- Investigators
- Principal Investigator: Glenn Bauman, MD London Health Sciences Centre, Lawson Health Research Institute